Pharmacogenetics of Nicotine Addiction Treatment (PNAT)

Trial Profile

Pharmacogenetics of Nicotine Addiction Treatment (PNAT)

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Varenicline (Primary) ; Nicotine
  • Indications Smoking withdrawal
  • Focus Biomarker; Therapeutic Use
  • Acronyms PNAT
  • Most Recent Events

    • 03 Dec 2015 Number of treatment arms has changed from 3 to 6 as reported by ClinicalTrials.gov record.
    • 03 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 10 Jan 2014 Planned number of patients changed from 1350 to 1200 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top